1. Home
  2. VTOL vs CSTL Comparison

VTOL vs CSTL Comparison

Compare VTOL & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

HOLD

Current Price

$44.45

Market Cap

1.2B

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$32.88

Market Cap

940.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTOL
CSTL
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
940.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VTOL
CSTL
Price
$44.45
$32.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
N/A
$46.67
AVG Volume (30 Days)
192.6K
403.7K
Earning Date
02-27-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
148.42
N/A
EPS
4.78
N/A
Revenue
$1,466,774,000.00
$343,530,000.00
Revenue This Year
$7.31
$2.88
Revenue Next Year
$9.48
N/A
P/E Ratio
$9.23
N/A
Revenue Growth
2.95
10.15
52 Week Low
$25.11
$14.59
52 Week High
$46.04
$44.28

Technical Indicators

Market Signals
Indicator
VTOL
CSTL
Relative Strength Index (RSI) 57.43 33.24
Support Level $43.63 $31.38
Resistance Level $46.04 $33.10
Average True Range (ATR) 1.47 1.93
MACD -0.22 -0.73
Stochastic Oscillator 32.76 14.92

Price Performance

Historical Comparison
VTOL
CSTL

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: